Table 1.

Plasma levels of fibrinolytic factors and TAFI in carriers of prothrombin G20210A mutation


Fibrinolytic factors and TAFI

Noncarriers

Carriers
Plasminogen, %   95.8 ± 12.2   93.3 ± 9.7  
α2-plasmin inhibitor, %   102.0 ± 13.1   98.2 ± 11.8  
t-PA, ng/mL   4.8 ± 2.6   5.1 ± 2.9  
PAI-1, U/mL   15.7 ± 5.1   14.2 ± 4.6  
TAFI, μg/mL
 
15.2 ± 8.3
 
14.8 ± 6.3
 

Fibrinolytic factors and TAFI

Noncarriers

Carriers
Plasminogen, %   95.8 ± 12.2   93.3 ± 9.7  
α2-plasmin inhibitor, %   102.0 ± 13.1   98.2 ± 11.8  
t-PA, ng/mL   4.8 ± 2.6   5.1 ± 2.9  
PAI-1, U/mL   15.7 ± 5.1   14.2 ± 4.6  
TAFI, μg/mL
 
15.2 ± 8.3
 
14.8 ± 6.3
 

For noncarriers, n = 30; for carriers, n = 32.

or Create an Account

Close Modal
Close Modal